BioCentury
ARTICLE | Company News

Bioventix, CardiNor deal

February 8, 2016 8:00 AM UTC

Bioventix will develop and provide antibodies for CardiNor’s Secretoneurin in vitro diagnostic (IVD) test. Secretoneurin is a neuropeptide shown to be an independent risk marker of cardiovascular dise...